PTD 988
Alternative Names: PTD-988Latest Information Update: 28 Mar 2025
At a glance
- Originator Pheno Therapeutics
- Class Small molecules
- Mechanism of Action G protein-coupled receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Neurological disorders
Most Recent Events
- 28 Feb 2025 Preclinical trials in Neurological disorders in United Kingdom (unspecified route) (Pheno Therapeutics pipeline, February 2025)